Mark A Plantz, Silvia Minardi, Joseph G Lyons, Allison C Greene, David J Ellenbogen, Mitchell Hallman, Jonathan T Yamaguchi, Soyeon Jeong, Chawon Yun, Adam E Jakus, Kenneth R Blank, Robert M Havey, Muturi Muriuki, Avinash G Patwardhan, Ramille N Shah, Wellington K Hsu, Stuart R Stock, Erin L Hsu
We recently developed a recombinant growth factor-free bone regenerative scaffold composed of stoichiometric hydroxyapatite (HA) ceramic particles and human demineralized bone matrix (DBM) particles (HA-DBM). Here, we performed the first pre-clinical comparative evaluation of HA-DBM relative to the industry standard and established positive control, recombinant human bone morphogenetic protein-2 (rhBMP-2), using a rat posterolateral spinal fusion model (PLF). Female Sprague-Dawley rats underwent bilateral L4-L5 PLF with implantation of the HA-DBM scaffold or rhBMP-2...
April 5, 2021: Acta Biomaterialia